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Application of a Physical Antimicrobial Spray Dressing for Reducing
Postoperative Peritoneal Dialysis Catheter Exit Site Infection in End-
stage Renal Failure Patients: A Prospective Cohort Study
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1United Christian Hospital, Kwun Tong, Hong Kong
2The Hong Kong Polytechnic University, Hung Hom, Hong Kong
Objective: Exit site infection (ESI) in the early stage of peritoneal dialysis
(PD) catheter insertion period which will disrupt healthy sinus tract forma-
tion and may lead to peritonitis and catheter removal. None of the current
strategies is considered a successful measure in preventing early ESI. The
aim of this study was to evaluate the effectiveness of JUC non-pharmaco-
logical, nano-technology physical antimicrobial spray dressing (JUC) on
postoperative PD exit site care with respect to reduction of infection risk
and patient comfort.
Methods: A prospective study was conducted from December 2012 to July
2014 and the results compared with a historical cohort data obtained be-
tween 2010 to 2011 in the same Renal unit (see table). JUC was adminis-
tered to exit sites of consenting subjects. The incidence rate of ESI, the
causative microorganisms and demographic data were compared between
the study and the retrospective control group. Pain was assessed by a
numeric pain score. An exit site swab culture was performed two weeks af-
ter PD catheter insertion to determine presence of colonizing organisms.
The patients were observed for ESI for 4 weeks.
Results:Of the 95 subjects completing the study, eight developed PD catheter
ESI. ESI incidence (within 4 weeks after PD catheter insertion) in the study
groupwas only 8.4%comparedwith 19% in thecontrol group, representing a sig-
nificant decrease in ESI by 56% (PZ 0.038, Chi-squared test). The causativemi-
croorganisms for ESI in the study group were coagulase-negative Staphylococci
(12.5%), Corynebacterium species (12.5%), Staphylococcus aureus (62.5%) and
Pseudomonas aeruginosa (12.5%). For the numeric pain score (0 to 10), 93% of
the subjects reported from 0 to 2. There were no adverse effects, skin discom-
fort nor delayed sinus epithelialization for wound healing reported.
Conclusion: JUC physical non-pharmacological nano-technology antimicro-
bial spray dressing is effective and safe in preventing early postoperative PD
catheter ESI.Historical
Control
(NZ 209)
Study
Group
(NZ 95)
P value
Sex Male 122 (58.37%) 50 (52.63%) 0.66
Female 87 (41.63%) 45 (47.36%)
Age Median 60 59 0.37545
Diabetes
history
Yes 119 (56.94%) 50 (52.63%) 0.5656
No 90 (43.06%) 45 (47.37%)
Immuno-
suppressant
drug
Yes 8 (3.83%) 3 (3.16%) 0.5
No 201 (96.17%) 92 (96.84%)
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Objective: To investigate the effect of astragaloside IV (AS-IV) on the regu-
lation of the TGF-b1 Smad signaling pathway in mesothelial cells with an
epithelial-to-mesenchymal transition (EMT).
Methods: EMT of human peritoneal mesothelial cells (HMrSV5) was induced
using 2 ng/ml TGF-b1. Cells were randomly divided into a vehicle group, a
vehicle group with AS-IV, a TGF-b1 treated group, and a TGF-b1 treated
group receiving varied doses of AS-IV or NAC. Real-time quantitative PCR
and western blot were used to detect the expression of genes and proteins
associated with the TGF-b1/Smad signaling pathway and EMT. DCFH-DA was
used to detect the generation of ROS in HMrSV5 cells, and a transwell migra-
tion assay was used to verify the capacity of AS-IV to inhibit EMT in HMrSV5
cells. Lentiviruses were used as carriers for the overexpression or knock-
down of the Smad7 gene.
Results: Expression levels of E-cadherin (epithelial marker) were decreased
and vimentin, a-SMA (EMT markers) and collagen I (extracellular matrix pro-
tein) phospho-Smad2/3, Snail1 and Snail2 was increased significantly in the
TGF-b1-treated HMrSV5 cells. AS-IV was associated with downregulated
expression of vimentin and phospho-Smad2/3 in a dose-dependent manner,
while the expression of Smad7 increased. Silenced or forced expression of
Smad7 verified its role in the inhibitory effect of AS-IV on TGF-b1-induced
EMT in HMrSV5 cells.
Conclusion: AS-IV effectively promotes the upregulation of Smad7 in the
TGF-b1/Smad signaling pathway during the EMT of HMrSV5 cells, indicating
its potential therapeutic effect for the control of PF.
Dialysis S117Figure 1. Chemical structure of Astragaloside IV.Figure 2. Effect of Astragaloside IV on HMrSV5 cell viability. Cells were
treated with various dose of Astragaloside IV (0,10,50,100,200, and
400 mg/ml) for 24 h (Fig. 2A) or 400 mg/ml Astragaloside IV for various times
(0,12,24,36,48 and 72 h) (Fig.2B). Neither enhanced cell proliferation nor
apoptosis were found in these cells.Figure 3. Effect of Astragaloside IV on TGF-b1-induced activation of Smad2/
3 and EMT in HMrSV5 cells. Cells were divided into a vehicle group (cells
treated with 0.1% DMSO), a TGF-b1 group (cells treated with 2 ng/ml TGF-
b1), an AS-IV group (cells treated with 400 mg/ml AS-IV) and an AS-IV +
TGF-b1 group (cells pretreated with AS-IV at 400 mg/ml 2 h prior to 2 ng/
ml TGF-b1). After incubation for 24 h, cells were lysed using RIPA buffer
or TRIzol reagent for a western blot assay and a quantitative real-time
PCR assay, respectively. Representative immunoblots of p-Smad, Smad2/3,
E-cadherin, Vimentin, a-SMA, collagen I, and GAPDH in HMrSV5 cells under
various treatments. GAPDH served as a loading control (A). Relative intensity
of p-Smad/Smad2/3, E-cadherin/GAPDH, Vimentin/GAPDH, a-SMA/GAPDH,
collagen I/GAPDH is shown in (B). Expression of Snail1 and Snail2 mRNA in
HMrSV5 cells under various treatments (C). *p< 0.05 vs. vehicle group,
#p< 0.05 vs. TGF-b1 group, nZ 3.Figure 4. Effect of Astragaloside IV on TGF-b1-induced activation of Smad2/3
and expression of Smad7, TGRBI and TGRBII in HMrSV5 cells. Cells were pre-
treated with AS-IV at various concentrations (0, 10, 100, 200, 400 mg/ml)
2 h prior to 2 ng/ml TGF-b1 treatment for 24 h and then lysed using RIPA buffer
or TRIzol reagent for a western blot assay and a quantitative real-time PCR
assay. The representative immunoblots of p-Smad, Smad2/3, Smad7, TGRBI,
TGRBII and GAPDH in HMrSV5 cells under various treatments (A). GAPDH
served as a loading control. Relative intensity of p-Smad/Smad2/3 and
Smad7/GAPDH is shown in (B). Expression of Smad7 mRNA in HMrSV5 cells un-
der various treatments (C) *p< 0.05 vs. vehicle group, nZ 3.
S118 DialysisFigure 5. Effects of Astragaloside IV on reactive oxygen species (ROS) pro-
duction, activation of Smad2/3 and expression of Smad7 in TGF-b1-treated
HMrSV5 cells. Cells were divided into a vehicle group (cells treated with
0.1% DMSO), a TGF-b1 group (cells treated with 10 ng/ml TGF-b1), an AS-
IV + TGF-b1 group (cells pretreated with AS-IV at 400 mg/ml 2 h prior to
2 ng/ml TGF-b1) and an NAC + TGF-b1 group (cells pretreated with NAC at
100 nM 2 h prior to 2 ng/ml TGF-b1). After incubation for 24 h, DCFH-DA fluo-
rescence in cultured cells was analyzed by fluorescence microscopy (A). The
quantification of fluorescence intensity is presented in the bar graphs (B).
Representative immunoblots of p-Smad, Smad2/3, Smad7 and Vimentin
are shown in (C), and GAPDH served as a loading control. Relative intensity
of p-Smad/Smad2/3, Smad7/GAPDH and vimentin/GAPDH is shown in (D).
*p< 0.05 vs. vehicle group, #p< 0.05 vs. TGF-b1 group, nZ 3.Figure 6. Effect of Smad7 on TGF-b1-induced EMT in HMrSV5 cells. Cells
were divided into a vehicle group (cells treated with 0.1% DMSO), TGF-b1
group (cells treated with 2 ng/ml TGF-b1), TGF-b1+ AS-IV group (cells pre-
treated with AS-IV at 400 mg/ml 2 h prior to 2 ng/ml TGF-b1), TGF-
b1+Smad7 overexpression group (after Smad7 enforced expression using a
Smad7-overexpression lentivirus, cells were treated with 2 ng/ml TGF-b1)
and TGF-b1 + AS-IV + Smad7 knockdown group (after Smad7 deletion using
a Smad7-inhibitor lentivirus, cells were pretreated with AS-IV at 400 mg/ml
2 h prior to 2 ng/ml TGF-b1). After incubation for 24 h, the levels of vimen-
tin, Smad7 and GAPDH (loading control) were analyzed by western blot (Fig.
6A). The migrating cells were detected by Giemsa staining (Fig.6B). A.
vehicle group; B. TGF-b1 group; C. TGF-b1+ AS-IV group; D. TGF-b1 + AS-IV
+ Smad7 knockdown group; E. TGF-b1+Smad7 overexpression group. The
quantification of the migrating cells is expressed graphically as a relative
fold increase of the vehicle (Fig. 6C). Six random fields for each insert
were counted, and three independent experiments were performed in
each group. *p< 0.05 vs. vehicle group, #p< 0.05 vs. TGF-b1 group, nZ 3.http://dx.doi.org/10.1016/j.hkjn.2015.09.1750034
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Objective: Hemodialysis (HD) patients frequently developed functional
impairment. The study used logistic regression analysis to identify predictors
for functional impairment in HD patients.
Methods: The study is a 5-year retrospective observational design. Patients
who received regular HD in a large HD center in southern Taiwan were
enrolled. Complete demographic data were available in 1166 patients for
the study period (2009 to 2013).
Karnofsky Performance Status Scale (KPS) score was used to quantify
functional status yearly in HD patients. A total 3509 KPS scores in person-
visit were collected. Clinical variables including demographics, laboratory
data, HD vintage were analyzed by logistic regression model for identifica-
tion predictors for functional status.
Results: The regression model yielded nineteen predictors those were statisti-
cally significant (p< 0.05). Further analysis with logistic regression model with
selected interaction showed older age, higher Hct, BUN, and glucose levels will
significance increase in the log-odds of getting low KPS score level in person-
visit. For interaction results, the combination of older age with higher albumin
level, higher creatinine level with longer HD treatment year will significance
decrease in the log-odds of getting low KPS score level in person-visit.
Conclusion: Age, serum albumin and creatinine levels, HD treatment years
are the main factors to influence functional status in HD patients.http://dx.doi.org/10.1016/j.hkjn.2015.09.1760077
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Objective: Depression and sleep disturbance are known to be potentially risk
factors that are associated with adverse outcomes including mortality in
end-stage renal disease (ESRD) patients. The severity of depression symptoms
and sleep disturbance following the start of dialysis treatment are independent
predictors of survival. The present study attempted to assess the prevalence
and related risk factors of depression and sleep disturbance among continuous
ambulatory peritoneal dialysis (CAPD) patients in Guangzhou, southern China.
Methods: A total of 57 patients on CAPD were enrolled in Memorial hospital of
Sun Yat-Sen University. Beck depression inventory (BDI) and Pittsburgh Sleep
Quality Index (PSQI) were applied to all patients for evaluating depression and
sleep quality respectively. Linear regression was performed to investigate the
associations between clinical data and BDI score, as well as PSQI score.
